首页>
外国专利>
21-day dosing schedule and method for fusion proteins comprising factor IX and human albumin for prophylactic treatment of hemophilia
21-day dosing schedule and method for fusion proteins comprising factor IX and human albumin for prophylactic treatment of hemophilia
展开▼
机译:包含因子IX和人白蛋白的融合蛋白预防血友病的21天给药时间表和方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a prophylactic dosing regimen using about 90-110 IU / kg of long-acting factor IX (human FIX / human albumin) at dosing intervals of approximately 3 weeks (eg, 21 days).
展开▼